UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Amendment No. )
Filed by
the Registrant x
Filed by a
Party other than the Registrant ¨
Check the appropriate box:
¨ |
Preliminary Proxy Statement |
¨ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
¨ |
Definitive Proxy Statement |
x |
Definitive Additional Materials |
¨ |
Soliciting Material Pursuant to §240.14a-12 |
COLISEUM ACQUISITION CORP. |
(Name of Registrant as Specified In Its Charter) |
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
Payment of Filing Fee (Check all boxes that apply):
x |
No fee required |
¨ |
Fee paid previously with preliminary materials |
¨ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): September 20, 2024
Coliseum Acquisition Corp.
(Exact name of registrant as specified in its charter)
Cayman Islands |
|
001-40514 |
|
98-1583230 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
1180
North Town Center Drive, Suite
100
Las Vegas, NV 89144
(Address of principal executive offices, including
zip code)
Registrant’s telephone number,
including area code: (702) 781-4313
Not Applicable
(Former name or former address,
if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each
exchange on which
registered |
Units, each consisting of one Class A ordinary share, par value $0.001 per share, and one-third of one redeemable warrant |
|
MITAU |
|
The Nasdaq Stock Market LLC |
Class A ordinary shares, par value $0.001 per share |
|
MITA |
|
The Nasdaq Stock Market LLC |
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
|
MITAW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01. Other Events.
As
previously disclosed, Coliseum Acquisition Corp. (the “Company”) has scheduled an extraordinary general meeting (the “Meeting”)
to seek shareholder approval of an amendment to the Company’s amended and restated memorandum and articles of association to extend
(the “Extension”) the date by which the Company must consummate an initial business combination, as described more
fully in the definitive proxy statement (the “Proxy Statement”), filed by the Company with the U.S. Securities and Exchange
Commission (the “SEC”) on September 3, 2024.
On September 20, 2024, the
Company determined to open the Meeting as scheduled on September 20, 2024 at 10:00 a.m. Eastern
Time, subject to the consent of the members of the Company constituting a quorum as set out in the Company’s amended and restated
articles of association, and then adjourn the Meeting to Tuesday, September 24, 2024, at 12:00 p.m. Eastern Time. Accordingly, the reconvened
Meeting will be held at 12:00 p.m., Eastern Time, at the offices of White & Case LLP, the Company’s legal counsel, located
at 1221 Avenue of the Americas, New York, NY 10020.
As previously disclosed, the Company has determined to allow redemption reversals so that no more than 2,000,000 shares remain in the
public float following redemptions. Shareholders
who have previously submitted shares for redemption or who have voted by proxy do not need to do anything prior to the Meeting unless
they change their decision as to redemption or voting. Shareholders may withdraw redemptions at any time until the vote is taken with
respect to the Extension. Shareholders may request to reverse their redemption by contacting the Company’s transfer agent, Continental
Stock Transfer & Trust Company, at One State Street, 30th Floor, New York, New York 10004 (e-mail: spacredemptions@continentalstock.com).
Additional Information
and Where to Find It
The
Company has filed with the SEC the Proxy Statement to be used at the Meeting, and has mailed the Proxy Statement to its shareholders
of record as of August 23, 2024. Investors and security holders of the Company are advised to read the Proxy Statement and any amendments
thereto, because these documents contain important information about the Meeting and the Company. Shareholders will also be able to obtain
copies of the Proxy Statement, without charge, at the SEC’s website at www.sec.gov or by directing a request to the Company’s
proxy solicitor, Sodali & Co, at 333 Ludlow Street, 5th Floor, South Tower, Stamford, CT 06902, Toll-Free (800) 662-5200 or (203)
658-9400, Email: MITA.info@investor.sodali.com, or to the Company at Coliseum Acquisition Corp., 1180 North Town
Center Drive, Suite 100, Las Vegas, NV 89144.
Participants in the
Solicitation
The
Company and its directors and executive officers may be considered participants in the solicitation of proxies with respect to the Meeting
under the rules of the SEC. Information about the directors and executive officers of the Company and a description of their interests
in the Company are set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which was filed
with the SEC on April 5, 2024 (the “Annual Report”) and the definitive Proxy Statement, which was filed with the SEC on September
3, 2024. These documents can be obtained free of charge from the sources indicated above.
Forward-Looking Statements
Certain
statements made in this Current Report are “forward looking statements” within the meaning of the “safe harbor”
provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees
of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important
factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from
those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include:
the inability of the Company to consummate a business combination within the time provided in the Company’s amended and restated
memorandum and articles of association; the level of redemptions made by the Company’s shareholders in connection with the Meeting
and its impact on the amount of funds available in the Company’s trust account to complete an initial business combination; and
those factors discussed in the Annual Report under the heading “Risk Factors,” and other documents of the Company filed,
or to be filed, with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise, except as required by law.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Coliseum Acquisition Corp. |
|
|
|
|
By: |
/s/ Harry You |
|
|
Name: |
Harry You |
|
|
Title: |
Executive Chairman |
|
|
|
Dated: September 20, 2024 |
|
|
Coliseum Acquisition (NASDAQ:MITAW)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Coliseum Acquisition (NASDAQ:MITAW)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024